AGL 38.40 Decreased By ▼ -0.16 (-0.41%)
AIRLINK 213.50 Increased By ▲ 5.73 (2.76%)
BOP 10.02 Decreased By ▼ -0.04 (-0.4%)
CNERGY 6.70 Decreased By ▼ -0.38 (-5.37%)
DCL 9.63 Decreased By ▼ -0.36 (-3.6%)
DFML 40.20 Decreased By ▼ -0.94 (-2.28%)
DGKC 100.52 Decreased By ▼ -2.94 (-2.84%)
FCCL 35.89 Decreased By ▼ -0.46 (-1.27%)
FFBL 89.00 Decreased By ▼ -2.59 (-2.83%)
FFL 14.32 Decreased By ▼ -0.28 (-1.92%)
HUBC 136.75 Decreased By ▼ -2.68 (-1.92%)
HUMNL 14.00 Decreased By ▼ -0.10 (-0.71%)
KEL 5.79 Decreased By ▼ -0.18 (-3.02%)
KOSM 7.33 Decreased By ▼ -0.53 (-6.74%)
MLCF 46.80 Decreased By ▼ -0.48 (-1.02%)
NBP 66.38 Decreased By ▼ -7.38 (-10.01%)
OGDC 220.56 Decreased By ▼ -2.10 (-0.94%)
PAEL 38.40 Increased By ▲ 0.29 (0.76%)
PIBTL 8.97 Decreased By ▼ -0.30 (-3.24%)
PPL 200.50 Decreased By ▼ -5.35 (-2.6%)
PRL 39.44 Decreased By ▼ -0.41 (-1.03%)
PTC 26.10 Decreased By ▼ -0.52 (-1.95%)
SEARL 105.40 Decreased By ▼ -4.84 (-4.39%)
TELE 9.15 Decreased By ▼ -0.08 (-0.87%)
TOMCL 37.35 Decreased By ▼ -0.86 (-2.25%)
TPLP 13.69 Decreased By ▼ -0.08 (-0.58%)
TREET 25.80 Decreased By ▼ -0.65 (-2.46%)
TRG 59.20 Decreased By ▼ -1.34 (-2.21%)
UNITY 33.45 Decreased By ▼ -0.69 (-2.02%)
WTL 1.76 Decreased By ▼ -0.12 (-6.38%)
BR100 12,093 Decreased By -206 (-1.67%)
BR30 37,918 Decreased By -959.2 (-2.47%)
KSE100 112,978 Decreased By -1883 (-1.64%)
KSE30 35,586 Decreased By -609.9 (-1.69%)

ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has sought feedback from the public and relevant stakeholders to finalise guidelines for hospital pharmacies.

According to DRAP, these standards are aimed at ensuring consistent, high-quality pharmacy services across the country in public and private hospitals, ultimately, benefiting patients and the healthcare system as a whole.

The public announcement stated: DRAP invites you to review the proposed guidelines and share your thoughts and suggestions. Your input will be invaluable in shaping the final document and ensuring it reflects the needs and expectations of patients, healthcare professionals, and the community.

The DRAP is to set hospital pharmacy guidelines in following four key areas: (i) Hospital Pharmacy Operations which include aspects like organizational structure, staffing, resources, policies, and procedures for managing medications from procurement and storage to dispensing and monitoring.

(ii) Medicine Use Management where the focus is on optimizing medication use within the hospital. This involves procedures for medication reconciliation, identifying potential issues, and implementing strategies to improve medication effectiveness and avoid medication-related harm.

(iii) Quality Improvement with believe in continuous improvement! These guidelines outline practices for assessing the effectiveness of hospital pharmacy services, identifying areas for improvement, and implementing corrective actions.And,

(iv) Human Resources Development for ensuring a competent and skilled pharmacy workforce is crucial. The guidelines address training and development programmes for all pharmacy personnel, from pharmacists to technicians. However, the health regulator has not given any timeline for the proposals.

Copyright Business Recorder, 2024

Comments

Comments are closed.